Accordion title open
Show Description
Accordion title close
Close Description

Graph showing the percentage of patients who had an A1C less than 5.7% at 40 weeks

Percentage of Patients With A1C <5.7% at 40 Weeks1,3†‡

ap<0.001 for superiority vs Ozempic 1 mg, adjusted for multiplicity.

Bar graph showing the percentage of adult patients with type 2 diabetes on metformin in the SURPASS-2 study who had an A1C less than 5.7% at 40 weeks. Graph shows Mounjaro vs Ozempic 1 mg. The bar graph shows the percentage of adult patients with type 2 diabetes on metformin in the SURPASS-2 study who had an A1C of less than 5.7% at 40 weeks. From a mean baseline A1C of 8.3%, 27% (Mounjaro 5 mg, n=470), 40% (Mounjaro 10 mg, n=469), 46% (Mounjaro 15 mg, n=469), and 19% (Ozempic 1 mg, n=468) of patients had an A1C of less than 5.7%.